Russia approves its third COVID-19 vaccine, CoviVac


  • World
  • Saturday, 20 Feb 2021

FILE PHOTO: Russian Prime Minister Mikhail Mishustin chairs a meeting with senior executives of the Central Office of Russian Government in Moscow, Russia January 19, 2021. Sputnik/Dmitry Astakhov/Pool via REUTERS

MOSCOW (Reuters) - Russia on Saturday approved a third coronavirus vaccine for domestic use, Prime Minister Mikhail Mishustin said on state TV, though large-scale clinical trials of the shot, labelled CoviVac and produced by the Chumakov Centre, have yet to begin.

Russia has already approved two COVID-19 vaccines, including the Sputnik V shot, developed by Moscow's Gamaleya Institute, following a similar approach of granting approval before seeing any late-stage trial results.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Restaurants are putting digital detox on the menu with smartphone-free dining
Ecuador president declares state of emergency over energy crisis
To stand out in the job market, get to grips with ChatGPT
U.S. stocks end mixed as fear index rises
Number of active drilling rigs in U.S. up this week
Huge blast at military base used by Iraqi Popular Mobilization Forces, army sources say
Three injured after chemical plant fire in U.S. Houston
North Korea conducts cruise missile warhead test on Friday, KCNA says
Feature: Sudanese fall back on primitive means to maintain livelihood amid war
Haiti's death toll rises as international support lags, UN report says

Others Also Read